FIELD: otolaryngology. SUBSTANCE: on the first treatment day, single intravenous drop-by-drop infusion of 5 ng bataleukin per 1 kg body weight diluted with physiologic solution is administered (sequent days), bataleukin is administered topically in volume 3-4 ml with concentration 20 ng/ml until local inflammation features cease. EFFECT: enhanced treatment efficiency. 2 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO TREAT CHRONIC PURULENT RHINOSINUSITIS | 2001 |
|
RU2178676C1 |
| METHOD FOR EVALUATING EFFICIENCY IN TREATMENT OF RHINOSINUSITES | 2001 |
|
RU2200319C1 |
| METHOD FOR DETERMINING PEROXIDASE ACTIVITY IN BIOLOGICAL FLUIDS | 2000 |
|
RU2180114C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN CHRONIC PURULENT RHINOSINUSITIS | 2008 |
|
RU2379050C2 |
| METHOD OF TREATMENT OF CHRONIC PURULENT RHINOSINUSITIS | 2007 |
|
RU2345784C1 |
| METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
| METHOD OF TREATING CHRONIC RHINOSINUSITIS WITH USING MAGNETIC NANOPARTICLES | 2012 |
|
RU2497528C1 |
| METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2009 |
|
RU2408385C1 |
| METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2580657C1 |
| METHOD OF TREATING PATIENTS WITH RHINOSINUSITIS | 2014 |
|
RU2564006C1 |
